NVS: Novartis AG
NVS exchange rate has changed by 0.23% for today. During the day, the instrument was traded at a low of 152.93 and at a high of 154.12.
Follow Novartis AG dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NVS News
- Bristol-Myers Squibb: Why I'm Bullish Ahead Of Q3 Earnings (NYSE:BMY)
- Will Nerlynx Continue to Aid Puma Biotechnology's Top Line in Q3?
- FDA Grants Orphan Drug Designation To Novartis’ Rapcabtagene Autoleucel For Treatment Of Idiopathic Inflammatory Myopathies
- Novartis: The Sell-Off Creates An Attractive Entry Point (NYSE:NVS)
- Why A Biotech M&A Wave May Hit This Winter
- Cancer Stocks to Consider as Oncology Innovation Accelerates
- NVS Wins FDA Nod for Label Expansion of Immunology Drug Rhapsido
- Former Highflier Argenx Plummets On A Surprise Setback In Sjogren's
- FDA Greenslights Novartis's Rhapsido as First Treatment for Chronic Friction Hives
- Novartis Receives FDA Approval For Rhapsido To Treat Symptomatic Dermographism
- Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal
- Agios' Growth Story Hinges on Mitapivat's Commercial Expansion
- Top 25 Attractive Dividend Stocks For October 2026
- Will Vertex's Kidney Disease Pipeline Be a New Growth Engine?
- A Federal Judge In Manhattan Ruled For Novartis On Wednesday Against Allegations That It Misused One Of Its Patents To Maintain Its Exclusivity On Its Blockbuster Heart-Failure Drug Entresto
- Ionis Delivers Positive Late-Stage Results for Two Partnered Drugs
- Celldex Prepares For 2027 FDA Submission for Chronic Skin Disease
- Amgen Boasts Success In Sjogren's; Shares Charge Ahead
- Cue Biopharma: Initiating 'Buy' Based On CUE-221 Trial Win CSU With Novel Dual MOA
- NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication
- Telix Beefs Up Radioisotopes Supply With $2.35 Billion Deal; Shares Crash
- 5 Undervalued Oncology Stocks Wall Street Is Overlooking (NASDAQ:IBB)
- Novartis Halts Experimental ALS Drug Trial but Acquires Brain Delivery Platform
- TG Therapeutics Makes A Bullish Move Amid Ongoing Roche Rivalry
Frequently Asked Questions
What is NVS stock price today?
Novartis AG stock is priced at 153.97 today. It trades within 152.93 - 154.12, yesterday's close was 153.61, and trading volume reached 2102. The live price chart of NVS shows these updates.
Does Novartis AG stock pay dividends?
Novartis AG is currently valued at 153.97. Dividend policy depends on the company, while investors also watch 25.12% and USD. View the chart live to track NVS movements.
How to buy NVS stock?
You can buy Novartis AG shares at the current price of 153.97. Orders are usually placed near 153.97 or 154.27, while 2102 and 0.52% show market activity. Follow NVS updates on the live chart today.
How to invest into NVS stock?
Investing in Novartis AG involves considering the yearly range 122.86 - 170.46 and current price 153.97. Many compare 8.25% and 3.94% before placing orders at 153.97 or 154.27. Explore the NVS price chart live with daily changes.
What are Novartis AG stock highest prices?
The highest price of Novartis AG in the past year was 170.46. Within 122.86 - 170.46, the stock fluctuated notably, and comparing with 153.61 helps spot resistance levels. Track Novartis AG performance using the live chart.
What are Novartis AG stock lowest prices?
The lowest price of Novartis AG (NVS) over the year was 122.86. Comparing it with the current 153.97 and 122.86 - 170.46 shows potential long-term entry points. Watch NVS moves on the chart live for more details.
When did NVS stock split?
Novartis AG has gone through stock splits historically. These changes are visible in , 153.61, and 25.12% after corporate actions.
- Previous Close
- 153.61
- Open
- 153.17
- Bid
- 153.97
- Ask
- 154.27
- Low
- 152.93
- High
- 154.12
- Volume
- 2.102 K
- Daily Change
- 0.23%
- Month Change
- 8.25%
- 6 Months Change
- 3.94%
- Year Change
- 25.12%
- Act
- -3.060 M
- Fcst
- -4.804 M
- Prev
- -8.557 M
- Act
- 0.987 M
- Fcst
- -0.153 M
- Prev
- 1.862 M
- Act
- Fcst
- Prev
- 5.420%